Related Experiment Video
Updated: May 7, 2026

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)
Published on: April 30, 2020
Contact investigation for active tuberculosis among child contacts in Uganda
Devan Jaganath1, Sarah Zalwango, Brenda Okware
1David Geffen School of Medicine at the University of California, Los Angeles.
Insights
Contact tracing in Uganda identified childhood tuberculosis cases early, preventing disease spread. Key risk factors included HIV, while BCG vaccination offered protection, guiding targeted screening efforts.
Area of Science:
- Pediatric infectious diseases
- Global health epidemiology
- Public health interventions
Background:
- Childhood tuberculosis (TB) remains a significant cause of illness and death globally.
- Limited research exists on pediatric TB, especially in high-burden regions where contact tracing is underutilized.
- This study addresses the need for better understanding of childhood TB and effective contact investigation strategies.
Purpose of the Study:
- To evaluate the effectiveness of contact tracing in identifying childhood tuberculosis in a resource-limited setting.
- To identify indicators of disease progression in child contacts of TB patients.
- To inform targeted screening strategies for pediatric TB.
Main Methods:
- A cohort of 761 child contacts (<15 years) in Kampala, Uganda, was followed for up to 24 months.
- Tuberculosis diagnosis was based on clinical, radiographic, and laboratory assessments.
- Isoniazid preventive therapy was administered to eligible children.
Main Results:
- The prevalence of tuberculosis among child contacts was 10%, with 71% confirmed by culture.
- Human immunodeficiency virus (HIV) infection and positive tuberculin skin tests were associated with increased TB risk (OR 7.90 and 2.21, respectively).
- BCG vaccination significantly protected children, particularly those aged ≤5 years (OR 0.23).
Conclusions:
- Contact tracing is effective in detecting culture-confirmed pediatric TB cases before dissemination in high-burden areas.
- Identifying risk factors like HIV and protective factors like BCG vaccination aids in targeted screening and management.
- This approach can help reduce morbidity and mortality associated with childhood tuberculosis.
Background:
Tuberculosis is a large source of morbidity and mortality among children. However, limited studies characterize childhood tuberculosis disease, and contact investigation is rarely implemented in high-burden settings. In one of the largest pediatric tuberculosis contact investigation studies in a resource-limited setting, we assessed the yield of contact tracing on childhood tuberculosis and indicators for disease progression in Uganda.
Methods:
Child contacts aged <15 years in Kampala, Uganda, were enrolled from July 2002 to June 2009 and evaluated for tuberculosis disease via clinical, radiographic, and laboratory methods for up to 24 months.
Results:
Seven hundred sixty-one child contacts were included in the analysis. Prevalence of tuberculosis in our child population was 10%, of which 71% were culture-confirmed positive. There were no cases of disseminated tuberculosis, and 483 of 490 children (99%) started on isoniazid preventative therapy did not develop disease. Multivariable testing suggested risk factors including human immunodeficiency virus (HIV) status (odds ratio [OR], 7.90; P < .001), and baseline positive tuberculin skin test (OR, 2.21; P = .03); BCG vaccination was particularly protective, especially among children aged ≤5 years (OR, 0.23; P < .001). Adult index characteristics such as sex, HIV status, and extent or severity of disease were not associated with childhood disease.
Conclusions:
Contact tracing for children in high-burden settings is able to identify a large percentage of culture-confirmed positive tuberculosis cases before dissemination of disease, while suggesting factors for disease progression to identify who may benefit from targeted screening.
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Investigation of Disease Outbreaks